December 1, 2022 bioAffinity Technologies will present at at Cell Bio during the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) Conference bioAffinity reports on a potential therapeutic approach that kills cancer cells without harm to normal cells David Elzi, Ph.D., bioAffinity Vice President of Research, will discuss his research into […]
November 17, 2022 bioAffinity Technologies will exhibit at the MEGA Lung event as part of the UTSA Health Fair on November 17, 2022.
October 19, 2022 bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference Powerful platform reveals the lung environment for diagnosing lung diseases Research Scientist Lydia Bederka, PhD, will present results of the Company’s research into the use of flow cytometry for analyzing the lung environment to detect diseases of the […]
September 11-14, 2022 bioAffinity Technologies Presents its CyPath® Lung test and Exhibits at the National Association of Veterans’ Research and Education Foundation (NAVREF) President and Chief Executive Officer Maria Zannes will speak about bioAffinity Technologies and CyPath® Lung, the Company’s non-invasive test to detect early-stage lung cancer, to senior research and medical professionals dedicated to […]
July 21, 2022 bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry Senior Vice President William Bauta, Ph.D., will present research leading to development of a product for use with flow cytometry, including its use with the Company’s non-invasive test CyPath® Lung that accurately detects early stage lung cancer. The new product is […]
April 28, 2022 bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection Chief Medical and Science Officer and Executive Vice President Vivienne Rebel, MD, PhD, will present at the Cleveland Clinic’s Advancing Early Lung Cancer Detection, an invitation-only symposium that brings together clinical experts, advocacy groups and industry […]